Drugs / NEMO-103
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07057037 | Sep 2025 → Apr 2026 overdue | articular cartilage disorder, frozen shoulder, rotator cuff syndrome, tendinitis +1 | Inventera Inc. | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NEMO-103 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07057037 ↗ |
| Known as | NEMO-103 Inj. | “MR arthrography enhanced with NEMO-103 injection (NEMO-103 Inj.) provides superior diagnostic imaging quality compared to unenhanced MRI” NCT07057037 ↗ |
| Route | Intravenous | “solution for Intravenous injection” NCT07057037 ↗ |